Synonym
Carzenide sodium; Carzenide sodium salt; Sodium p-sulfamoylbenzoate; Carzenidum; Carzenida;
IUPAC/Chemical Name
sodium 4-sulfamoylbenzoate
InChi Key
FWOKISIYDJIISA-UHFFFAOYSA-M
InChi Code
InChI=1S/C7H7NO4S.Na/c8-13(11,12)6-3-1-5(2-4-6)7(9)10;/h1-4H,(H,9,10)(H2,8,11,12);/q;+1/p-1
SMILES Code
[Na+].NS(=O)(=O)C1=CC=C(C=C1)C([O-])=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
223.18
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Beyer J, Bierl A, Peters FT, Maurer HH. Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation. Ther Drug Monit. 2005 Aug;27(4):509-20. doi: 10.1097/01.ftd.0000160719.96445.91. PMID: 16044110.
2: Shetnev A, Shlenev R, Efimova J, Ivanovskii S, Tarasov A, Petzer A, Petzer JP. 1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B. Bioorg Med Chem Lett. 2019 Nov 1;29(21):126677. doi: 10.1016/j.bmcl.2019.126677. Epub 2019 Sep 10. PMID: 31537422.
3: Corcuera A, Stolle K, Hillmer S, Seitz S, Lee JY, Bartenschlager R, Birkmann A, Urban A. Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro. Antiviral Res. 2018 Oct;158:135-142. doi: 10.1016/j.antiviral.2018.07.011. Epub 2018 Jul 20. PMID: 30031759.
4: New bitter blocker discovered, study finds. J Am Dent Assoc. 2011 Aug;142(8):901. doi: 10.14219/jada.archive.2011.0291. PMID: 21919220.
5: Patil R, Fells JI, Szabó E, Lim KG, Norman DD, Balogh A, Patil S, Strobos J, Miller DD, Tigyi GJ. Design and synthesis of sulfamoyl benzoic acid analogues with subnanomolar agonist activity specific to the LPA2 receptor. J Med Chem. 2014 Aug 28;57(16):7136-40. doi: 10.1021/jm5007116. Epub 2014 Aug 12. PMID: 25100502; PMCID: PMC4148159.
6: Eckhardt K, King MT, Gocke E, Wild D. Mutagenicity study of Remsen-Fahlberg saccharin and contaminants. Toxicol Lett. 1980 Nov;7(1):51-60. doi: 10.1016/0378-4274(80)90085-5. PMID: 6794189.
7: Ullrich KJ, Fritzsch G, Rumrich G, David C. Polysubstrates: substances that interact with renal contraluminal PAH, sulfate, and NMeN transport: sulfamoyl-, sulfonylurea-, thiazide- and benzeneamino-carboxylate (nicotinate) compounds. J Pharmacol Exp Ther. 1994 May;269(2):684-92. PMID: 8182536.
8: Poncelet F, Mercier M, Lederer J. Saccharin: para forms of some impurities are not mutagenic in Salmonella typhimurium. Food Cosmet Toxicol. 1980 Aug;18(4):453. doi: 10.1016/0015-6264(80)90236-9. PMID: 7007186.
9: HAMOR GH, JANFAZA M. Synthesis of alkyl esters of 4-amino-2-sulfamoylbenzoic acid. J Pharm Sci. 1963 Jan;52:102-3. doi: 10.1002/jps.2600520126. PMID: 13952427.
10: Palfrey HC, Silva P, Epstein FH. Sensitivity of cAMP-stimulated salt secretion in shark rectal gland to "loop" diuretics. Am J Physiol. 1984 Mar;246(3 Pt 1):C242-6. doi: 10.1152/ajpcell.1984.246.3.C242. PMID: 6322593.
